SWITCH PATTERNS AND TOTAL COSTS IN BIOLOGIC-NAIVE PATIENTS INITIATING APREMILAST OR A BIOLOGIC FOR THE TREATMENT OF PSORIASIS

被引：0
|
作者：
Wu, J. [1 ]
Pelletier, C. [2 ]
Ung, B. [2 ]
Tian, M. [2 ]
Ni, Q. [2 ]
Curtis, J. R. [3 ]
机构：
[1] Kaiser Permanente Los Angeles Med Ctr, Los Angeles, CA USA
[2] Celgene Corp, Summit, NJ USA
[3] Univ Alabama Birmingham, Birmingham, AL USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.2523
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSS23
引用
收藏
页码：S426 / S426
页数：1
相关论文
共 50 条
  • [1] Real-world switch patterns and healthcare costs in biologic-naive psoriasis patients initiating apremilast or biologics
    Wu, Jashin J.
    Pelletier, Corey
    Ung, Brian
    Tian, Marc
    Khilfeh, Ibrahim
    Curtis, Jeffrey R.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (11) : 767 - 779
  • [2] SWITCH PATTERNS AND TOTAL HEALTHCARE COSTS IN BIOLOGIC-NAIVE PATIENTS INITIATING APREMILAST OR A BIOLOGIC FOR THE TREATMENT OF PSORIATIC ARTHRITIS: RESULTS FROM A US CLAIMS ANALYSIS
    Curtis, J. R.
    Pelletier, C.
    Ung, B.
    Tian, M.
    Ni, Q.
    Wu, J.
    VALUE IN HEALTH, 2018, 21 : S293 - S294
  • [3] Treatment patterns and costs among biologic-naive patients initiating apremilast or biologics for psoriatic arthritis
    Feldman, Steven R.
    Pelletier, Corey L.
    Wilson, Kathleen L.
    Mehta, Rina K.
    Brouillette, Matthew A.
    Smith, David
    Bonafede, Machaon M.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (09) : 699 - 708
  • [4] Real-world treatment patterns and healthcare costs among biologic-naive patients initiating apremilast or biologics for the treatment of psoriasis
    Wu, Jashin J.
    Pelletier, Corey
    Ung, Brian
    Tian, Marc
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (04) : 365 - 371
  • [5] Switch Rates and Total Cost of Care Associated with Apremilast and Biologic Therapies in Biologic-Naive Patients with Plaque Psoriasis
    Kaplan, David L.
    Ung, Brian L.
    Pelletier, Corey
    Udeze, Chuka
    Khilfeh, Ibrahim
    Tian, Marc
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2020, 12 : 369 - 377
  • [6] Real-world US healthcare costs of psoriasis for biologic-naive patients initiating apremilast or biologics
    Feldman, Steven R.
    Pelletier, Corey L.
    Wilson, Kathleen L.
    Mehta, Rina K.
    Brouillette, Matthew A.
    Smith, David
    Bonafede, Machaon M.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (01) : 45 - 54
  • [7] Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis
    Wu, Jashin J.
    Pelletier, Corey
    Ung, Brian
    Tian, Marc
    Khilfeh, Ibrahim
    Curtis, Jeffrey R.
    ADVANCES IN THERAPY, 2020, 37 (05) : 2098 - 2115
  • [8] COMPARISON OF TREATMENT SWITCHING AMONG BIOLOGIC-NAIVE PSORIASIS PATIENTS INITIATING APREMILAST OR BIOLOGIC TREATMENT: RESULTS FROM A US CLAIMS DATABASE
    Kaplan, D.
    Ung, B.
    Pelletier, C.
    Udeze, C.
    Tian, M.
    VALUE IN HEALTH, 2019, 22 : S364 - S364
  • [9] Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis
    Jashin J. Wu
    Corey Pelletier
    Brian Ung
    Marc Tian
    Ibrahim Khilfeh
    Jeffrey R. Curtis
    Advances in Therapy, 2020, 37 : 2098 - 2115
  • [10] REAL-WORLD COSTS IN BIOLOGIC-NAIVE PSORIASIS PATIENTS INITIATING APREMILAST OR BIOLOGICS IN A US HEALTHCARE CLAIMS DATABASE
    Kaplan, D.
    Ung, B.
    Pelletier, C.
    Udeze, C.
    Tian, M.
    VALUE IN HEALTH, 2019, 22 : S888 - S888
12345